Blog Voices from the Frontlines
By Jesse Carpender for Cashinbis
Commercialization of cannabis has increased the need for quality control and science-based education within the industry. The Patient Focused Certification Program, a project of Americans for Safe Access, aims to address both of these needs.
Jahan Marcu, Ph.D., has helped set worldwide standards for the cannabis industry as director for the Patient Focused Certification Program. Dr. Marcu is also Chief Scientific Officer for Americans for Safe Access. He serves on the board of directors of the International Association for Cannabinoids as Medicine (IACM). He received his Ph.D. for significant contributions to the study of the structure and function of the CB1 receptor, and the role of the endocannabinoid system in bone.
For Marcu, science-based education is essential to cannabis businesses.
“Consistency and quality of information is a liability for operations if staff are providing information to patients that is not based in scientific literature,” he said.
On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA). This report, in large part, scrutinized Representative Tom Marino (R-PA) and his potential appointment as the head of the Office of National Drug Control Policy (ONDCP) also known as the Drug Czar because of his ties with and sponsorship of legislation favoring the pharmaceutical industry.
4-Year Trend of Rising Opioid Deaths Reversed in Colorado After Marijuana Legalization - Americans for Safe Access
Since legal recreational marijuana sales began in Colorado in January 2014, the state has seen a 6 percent drop in opioid deaths, according to research published in the American Journal of Public Health. The drop follows 14 years of rising opioid deaths, going back to the first year for which the researchers had data.
(Prague, 16th October 2017) International Cannabis and Cannabinoids Institute (ICCI) welcomes Ethan Russo, MD as the new Director of Research and Development. ICCI is the first-ever international Center of Excellence for the advancement of cannabis and cannabinoid treatments located in the Czech Republic. ICCI identifies, coordinates, and supports global research priorities for the advancement of cannabis and cannabinoid treatments through a multidiscipline evidence-based approach that incorporates innovative tools and approaches.
In the October 2017 Issue:
- ASA Weighs in as World Health Org Considers CBD
- PFC Educating Doctors, Conducting Trainings in 3 States
- American Legion Urges VA Secretary to Back Medical Cannabis Study
- New Bipartisan Bill to Aid Cannabis Research
- DC May Expand Access to Medical Cannabis to Stem Opioid Crisis
- Acting DEA Chief Resigns, Longtime Deputy Appointed
- ASA Activist Profile: Amy Mellen, Maryland
- ACTION ALERT: End Pain, Not Lives – Sign the Petition Today
Too often we forget to thank Members of Congress who show their support for medical cannabis patients and their access to medicine. Please take a moment today to use the links below to tweet a quick "thank you" to the original sponsors and co-sponsors of the CARERS Act of 2017.
If your Member of Congress is not a co-sponsor yet, send them a message and ask them to co-sponsor CARERS today!
If nothing is done, we can expect a lot of people to die: A forecast by STAT concluded that as many as 650,000 people will die over the next 10 years from opioid overdoses — more than the entire city of Baltimore. The US risks losing the equivalent of a whole American city in just one decade.
The use of cannabis in response to the opioid crisis: A review of the literature - Americans for Safe Access
A staggering number of Americans are dying from overdoses attributed to prescription opioid medications (POMs). In response, states are creating policies related to POM harm reduction strategies, overdose prevention, and alternative therapies for pain management, such as cannabis (medical marijuana). However, little is known about how the use of cannabis for pain management may be associated with POM use.
Medical marijuana patients report reduction in use of prescription drugs - Americans for Safe Access
Some medical marijuana patients in Illinois say the drug has allowed them to reduce or eliminate their use of other prescription medication, a new study reports. The study by DePaul and Rush universities was small, with 30 participants, and involved only those who volunteered to respond to the topic, so researchers conceded the results might be biased in favor of marijuana. But it's believed to be the first peer-reviewed, published research of medical marijuana patients in Illinois.
In an attempt to reduce opioid use amid a nationwide abuse epidemic, insurance giant Cigna will no longer cover most OxyContin prescriptions in its group plans beginning January 1. "Our focus is on helping customers get the most value from their medications -- this means obtaining effective pain relief while also guarding against opioid misuse," Cigna Chief Pharmacy Officer Jon Maesner said in a statement Wednesday.